Upstream Bio, Inc.
UPB
$9.71
$0.9310.59%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | ||
|---|---|---|---|---|---|
| Net Income | -79.51% | -415.54% | -356.48% | -356.48% | |
| Total Depreciation and Amortization | 250.00% | -17.65% | -10.34% | -10.34% | |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | |
| Total Other Non-Cash Items | 1,202.28% | 127.11% | 68.78% | 68.78% | |
| Change in Net Operating Assets | 67.28% | -76.55% | 174.21% | 174.21% | |
| Cash from Operations | -21.74% | -189.73% | -50.60% | -50.60% | |
| Capital Expenditure | -- | -- | -- | -- | |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | |
| Cash Acquisitions | -- | -- | -- | -- | |
| Divestitures | -- | -- | -- | -- | |
| Other Investing Activities | 903.00% | -85.84% | -14.60% | -14.60% | |
| Cash from Investing | 899.47% | -88.50% | -14.42% | -14.42% | |
| Total Debt Issued | -- | -- | -- | -- | |
| Total Debt Repaid | -- | -- | -- | -- | |
| Issuance of Common Stock | -- | -81.00% | 522.22% | 522.22% | |
| Repurchase of Common Stock | -- | -- | -- | -- | |
| Issuance of Preferred Stock | -- | -- | 15.67% | 15.67% | |
| Repurchase of Preferred Stock | -- | -- | -- | -- | |
| Total Dividends Paid | -- | -- | -- | -- | |
| Other Financing Activities | -- | -- | -- | -- | |
| Cash from Financing | 203,594.74% | -3,382.00% | 15.64% | 15.64% | |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | |
| Net Change in Cash | 1,463.48% | -289.76% | -5.63% | -5.63% | |